Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity
Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.
Highlighted with 141 tables and 111 figures, this 258-page report “Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Highlighted with 141 tables and 111 figures, this 258-page report “Global Active Pharmaceutical Ingredients (API) Market 2022-2032 by Molecule (Small, Large), Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global active pharmaceutical ingredients (API) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
Based on Molecule, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.
- Small Molecule APIs
- Large Molecule APIs
- Synthetic API
- Branded Synthetic API
- Generic Synthetic API
- Biotech API
- by type
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Other Biotech APIs
- by Category
- Innovative Biologic API
- Generic Biosimilar API
- by Expression
- Mammalian Expression
- Microbial Expression
- Yeast Expression
- Insect Expression
- Other Expression Technologies
- HPAPI
- Branded HPAPI
- Generic HPAPI
- Captive Manufacturing
- Branded Captive API
- Generic Captive API
- Merchant Manufacturing
- by Drug Type
- Branded Merchant API
- Generic Merchant API
- by Drug Synthesis
- Merchant Synthetic API
- Merchant Biotech API
- Infectious Diseases
- Oncology
- Ophthalmology
- Cardiovascular Disorders
- Central Nervous System
- Pulmonary Disorders
- Orthopedics
- Other Applications
- Branded Prescription Drugs
- Generic Prescription Drugs
- OTC Drugs
- North America (U.S., Canada, and Mexico)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
- APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (UAE, Saudi Arabia, South Africa and Rest of MEA)
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY MOLECULE
3.1 Market Overview by Molecule
3.2 Small Molecule APIs
3.3 Large Molecule APIs
4 SEGMENTATION OF GLOBAL MARKET BY SYNTHESIS
4.1 Market Overview by Synthesis
4.2 Synthetic API
4.2.1 Branded Synthetic API
4.2.2 Generic Synthetic API
4.3 Biotech API
4.3.1 Biotech API by Drug Type
4.3.1.1 Monoclonal Antibodies
4.3.1.2 Recombinant Proteins
4.3.1.3 Vaccines
4.3.1.4 Other Biotech APIs
4.3.2 Biotech API by Category
4.3.2.1 Innovative Biologic API
4.3.2.2 Generic Biosimilar API
4.3.3 Biotech API by Expression Technology
4.3.3.1 Mammalian Expression
4.3.3.2 Microbial Expression
4.3.3.3 Yeast Expression
4.3.3.4 Insect Expression
4.3.3.5 Other Expression Technologies
4.4 HPAPI
4.4.1 Branded HPAPI
4.4.2 Generic HPAPI
5 SEGMENTATION OF GLOBAL MARKET BY MANUFACTURING PROCESS
5.1 Market Overview by Manufacturing Process
5.2 Captive Manufacturing
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant Manufacturing
5.3.1 Merchant Manufacturing by Drug Type
5.3.1.1 Branded Merchant API
5.3.1.2 Generic Merchant API
5.3.2 Merchant Manufacturing by Drug Synthesis
5.3.2.1 Merchant Synthetic API
5.3.2.2 Merchant Biotech API
6 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC APPLICATION
6.1 Market Overview by Therapeutic Application
6.2 Infectious Diseases
6.3 Oncology
6.4 Ophthalmology
6.5 Cardiovascular Disorders
6.6 Central Nervous System
6.7 Pulmonary Disorders
6.8 Orthopedics
6.9 Other Applications
7 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE
7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs
8 SEGMENTATION OF GLOBAL MARKET BY REGION
8.1 Geographic Market Overview 2022-2032
8.2 North America Market 2022-2032 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2022-2032 by Country
8.3.1 Overview of European Market
8.3.2 UK
8.3.3 France
8.3.4 Germany
8.3.5 Spain
8.3.6 Italy
8.3.7 Russia
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2022-2032 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 China
8.4.3 Japan
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2022-2032 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2022-2032 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Related Reports and Products
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 MARKET OVERVIEW AND DYNAMICS
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 SEGMENTATION OF GLOBAL MARKET BY MOLECULE
3.1 Market Overview by Molecule
3.2 Small Molecule APIs
3.3 Large Molecule APIs
4 SEGMENTATION OF GLOBAL MARKET BY SYNTHESIS
4.1 Market Overview by Synthesis
4.2 Synthetic API
4.2.1 Branded Synthetic API
4.2.2 Generic Synthetic API
4.3 Biotech API
4.3.1 Biotech API by Drug Type
4.3.1.1 Monoclonal Antibodies
4.3.1.2 Recombinant Proteins
4.3.1.3 Vaccines
4.3.1.4 Other Biotech APIs
4.3.2 Biotech API by Category
4.3.2.1 Innovative Biologic API
4.3.2.2 Generic Biosimilar API
4.3.3 Biotech API by Expression Technology
4.3.3.1 Mammalian Expression
4.3.3.2 Microbial Expression
4.3.3.3 Yeast Expression
4.3.3.4 Insect Expression
4.3.3.5 Other Expression Technologies
4.4 HPAPI
4.4.1 Branded HPAPI
4.4.2 Generic HPAPI
5 SEGMENTATION OF GLOBAL MARKET BY MANUFACTURING PROCESS
5.1 Market Overview by Manufacturing Process
5.2 Captive Manufacturing
5.2.1 Branded Captive API
5.2.2 Generic Captive API
5.3 Merchant Manufacturing
5.3.1 Merchant Manufacturing by Drug Type
5.3.1.1 Branded Merchant API
5.3.1.2 Generic Merchant API
5.3.2 Merchant Manufacturing by Drug Synthesis
5.3.2.1 Merchant Synthetic API
5.3.2.2 Merchant Biotech API
6 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC APPLICATION
6.1 Market Overview by Therapeutic Application
6.2 Infectious Diseases
6.3 Oncology
6.4 Ophthalmology
6.5 Cardiovascular Disorders
6.6 Central Nervous System
6.7 Pulmonary Disorders
6.8 Orthopedics
6.9 Other Applications
7 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE
7.1 Market Overview by Drug Type
7.2 Branded Prescription Drugs
7.3 Generic Prescription Drugs
7.4 OTC Drugs
8 SEGMENTATION OF GLOBAL MARKET BY REGION
8.1 Geographic Market Overview 2022-2032
8.2 North America Market 2022-2032 by Country
8.2.1 Overview of North America Market
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 European Market 2022-2032 by Country
8.3.1 Overview of European Market
8.3.2 UK
8.3.3 France
8.3.4 Germany
8.3.5 Spain
8.3.6 Italy
8.3.7 Russia
8.3.8 Rest of European Market
8.4 Asia-Pacific Market 2022-2032 by Country
8.4.1 Overview of Asia-Pacific Market
8.4.2 China
8.4.3 Japan
8.4.4 India
8.4.5 Australia
8.4.6 South Korea
8.4.7 Rest of APAC Region
8.5 South America Market 2022-2032 by Country
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America Market
8.6 MEA Market 2022-2032 by Country
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Other National Markets
9 COMPETITIVE LANDSCAPE
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
AbbVie Inc.
Astrazeneca
Aurobindo Pharma Ltd.
BASF
Bayer AG
Boehringer Ingelheim
Catalent Inc.
Dr. Reddy's Laboratories
F. Hoffmann-La Roche
GlaxoSmithKline plc
Lonza Group
Lupin Limited
Merck & Co., Inc.
Mylan NV
Novartis International AG
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Related Reports and Products
LIST OF TABLES:
Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 7. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market
Table 8. Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn
Table 14. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 16. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn
Table 17. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn
Table 18. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn
Table 19. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 20. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn
Table 21. Global Active Pharmaceutical Ingredients (API) Market by Region, 2022-2032, $ bn
Table 22. Leading National Active Pharmaceutical Ingredients (API) Market, 2022 and 2032, $ bn
Table 23. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 25. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 26. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 27. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, % based on Dollar Value
Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 29. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 30. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 32. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 33. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 34. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 35. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 36. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 37. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 38. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 39. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 40. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 41. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 42. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 43. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 44. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 45. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 46. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 47. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 48. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 49. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 50. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 51. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 52. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 53. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn
Table 54. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 55. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 56. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 57. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 58. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 59. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 60. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 61. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 62. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 63. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 64. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 65. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 66. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 67. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 68. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 69. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 70. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn
Table 71. South America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 72. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 73. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 74. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 75. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 76. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 77. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 78. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 79. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 80. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 81. MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 82. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 83. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 84. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 85. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 86. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 87. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 88. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 89. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 90. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 91. AbbVie Inc.: Company Snapshot
Table 92. AbbVie Inc.: Business Segmentation
Table 93. AbbVie Inc.: Product Portfolio
Table 94. Astrazeneca: Company Snapshot
Table 95. Aurobindo Pharma Ltd.: Company Snapshot
Table 96. Aurobindo Pharma Ltd.: Product Portfolio
Table 97. BASF: Company Snapshot
Table 98. BASF: Business Segmentation
Table 99. Bayer AG: Company Snapshot
Table 100. Bayer AG: Business Segmentation
Table 101. Bayer AG: Product Portfolio
Table 102. Boehringer Ingelheim: Company Snapshot
Table 103. Boehringer Ingelheim: Product Portfolio
Table 104. Catalent Inc.: Company Snapshot
Table 105. Catalent Inc.: Business Segmentation
Table 106. Catalent Inc.: Product Portfolio
Table 107. Dr. Reddy's Laboratories: Company Snapshot
Table 108. Dr. Reddy's Laboratories: Business Segmentation
Table 109. F. Hoffmann-La Roche: Company Snapshot
Table 110. F. Hoffmann-La Roche: Clinical Trial Service
Table 111. F. Hoffmann-La Roche: Business Segmentation
Table 112. F. Hoffmann-La Roche: Revenue by Region
Table 113. GlaxoSmithKline: Company Snapshot
Table 114. GlaxoSmithKline: Business Segmentation
Table 115. GlaxoSmithKline: Product Portfolio
Table 116. Lonza Group: Company Snapshot
Table 117. Lonza Group: Business Segmentation
Table 118. Lonza Group: Product Portfolio
Table 119. Lupin Limited: Company Snapshot
Table 120. Lupin Limited: Business Segmentation
Table 121. Merck & Co., Inc.: Company Snapshot
Table 122. Merck & Co., Inc.: Business Segmentation
Table 123. Mylan NV: Company Snapshot
Table 124. Mylan NV: Breakdown of Revenue by Region, 2022
Table 125. Mylan NV: Breakdown of Revenue by Product Category, 2022
Table 126. Novartis International AG: Company Snapshot
Table 127. Novartis International AG: Business Segmentation
Table 128. Pfizer Inc.: Company Snapshot
Table 129. Pfizer Inc.: Business Segmentation
Table 130. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 131. Pfizer Inc.: Breakdown of Revenue by Region
Table 132. Pfizer Inc.: Product Portfolio
Table 133. Sanofi: Company Snapshot
Table 134. Sanofi: Business Segmentation
Table 135. Sanofi: Breakdown of Revenue by Region
Table 136. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 137. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 138. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 139. Thermo Fisher Scientific: Company Snapshot
Table 140. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, %
Table 141. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, %
Table 1. Snapshot of Global Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 7. Main Product Trends and Market Opportunities in Global Active Pharmaceutical Ingredients (API) Market
Table 8. Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, $ bn
Table 9. Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 10. Global Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2022-2032, $ bn
Table 11. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2022-2032, $ bn
Table 12. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2022-2032, $ bn
Table 13. Global Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2022-2032, $ bn
Table 14. Global Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2022-2032, $ bn
Table 15. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 16. Global Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2022-2032, $ bn
Table 17. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2022-2032, $ bn
Table 18. Global Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2022-2032, $ bn
Table 19. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 20. Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, $ bn
Table 21. Global Active Pharmaceutical Ingredients (API) Market by Region, 2022-2032, $ bn
Table 22. Leading National Active Pharmaceutical Ingredients (API) Market, 2022 and 2032, $ bn
Table 23. North America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 24. U.S. Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 25. U.S. Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 26. U.S. Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 27. Top 15 Countries Supplying API for Medicines Consumed in the US, 2019, % based on Dollar Value
Table 28. Canada Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 29. Canada Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 30. Canada Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 31. Mexico Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 32. Mexico Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 33. Mexico Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 34. Europe Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 35. UK Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 36. UK Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 37. UK Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 38. France Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 39. France Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 40. France Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 41. Germany Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 42. Germany Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 43. Germany Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 44. Spain Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 45. Spain Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 46. Spain Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 47. Italy Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 48. Italy Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 49. Italy Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 50. Russia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 51. Russia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 52. Russia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 53. Active Pharmaceutical Ingredients (API) Market in Rest of Europe by Country, 2022-2032, $ bn
Table 54. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 55. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 56. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 57. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 58. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 59. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 60. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 61. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 62. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 63. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 64. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 65. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 66. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 67. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 68. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 69. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 70. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2022-2032, $ bn
Table 71. South America Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 72. Argentina Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 73. Argentina Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 74. Argentina Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 75. Brazil Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 76. Brazil Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 77. Brazil Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 78. Chile Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 79. Chile Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 80. Chile Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 81. MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022-2032, $ bn
Table 82. UAE Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 83. UAE Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 84. UAE Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 85. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 86. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 87. Saudi Arabia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 88. South Africa Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, $ bn
Table 89. South Africa Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, $ bn
Table 90. South Africa Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, $ bn
Table 91. AbbVie Inc.: Company Snapshot
Table 92. AbbVie Inc.: Business Segmentation
Table 93. AbbVie Inc.: Product Portfolio
Table 94. Astrazeneca: Company Snapshot
Table 95. Aurobindo Pharma Ltd.: Company Snapshot
Table 96. Aurobindo Pharma Ltd.: Product Portfolio
Table 97. BASF: Company Snapshot
Table 98. BASF: Business Segmentation
Table 99. Bayer AG: Company Snapshot
Table 100. Bayer AG: Business Segmentation
Table 101. Bayer AG: Product Portfolio
Table 102. Boehringer Ingelheim: Company Snapshot
Table 103. Boehringer Ingelheim: Product Portfolio
Table 104. Catalent Inc.: Company Snapshot
Table 105. Catalent Inc.: Business Segmentation
Table 106. Catalent Inc.: Product Portfolio
Table 107. Dr. Reddy's Laboratories: Company Snapshot
Table 108. Dr. Reddy's Laboratories: Business Segmentation
Table 109. F. Hoffmann-La Roche: Company Snapshot
Table 110. F. Hoffmann-La Roche: Clinical Trial Service
Table 111. F. Hoffmann-La Roche: Business Segmentation
Table 112. F. Hoffmann-La Roche: Revenue by Region
Table 113. GlaxoSmithKline: Company Snapshot
Table 114. GlaxoSmithKline: Business Segmentation
Table 115. GlaxoSmithKline: Product Portfolio
Table 116. Lonza Group: Company Snapshot
Table 117. Lonza Group: Business Segmentation
Table 118. Lonza Group: Product Portfolio
Table 119. Lupin Limited: Company Snapshot
Table 120. Lupin Limited: Business Segmentation
Table 121. Merck & Co., Inc.: Company Snapshot
Table 122. Merck & Co., Inc.: Business Segmentation
Table 123. Mylan NV: Company Snapshot
Table 124. Mylan NV: Breakdown of Revenue by Region, 2022
Table 125. Mylan NV: Breakdown of Revenue by Product Category, 2022
Table 126. Novartis International AG: Company Snapshot
Table 127. Novartis International AG: Business Segmentation
Table 128. Pfizer Inc.: Company Snapshot
Table 129. Pfizer Inc.: Business Segmentation
Table 130. Pfizer Inc.: Breakdown of Revenue by Product Category
Table 131. Pfizer Inc.: Breakdown of Revenue by Region
Table 132. Pfizer Inc.: Product Portfolio
Table 133. Sanofi: Company Snapshot
Table 134. Sanofi: Business Segmentation
Table 135. Sanofi: Breakdown of Revenue by Region
Table 136. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 137. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 138. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 139. Thermo Fisher Scientific: Company Snapshot
Table 140. Thermo Fisher Scientific: Breakdown of Revenue by Business Segment, 2020, %
Table 141. Thermo Fisher Scientific: Breakdown of Revenue by Region, 2020, %
LIST OF FIGURES:
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2022, $ thousand
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market
Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue
Figure 15. Global Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%)
Figure 16. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn
Figure 17. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn
Figure 18. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue
Figure 19. Contribution to Global 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 20. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn
Figure 21. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn
Figure 22. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn
Figure 23. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn
Figure 24. Global Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn
Figure 25. Global Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn
Figure 26. Global Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn
Figure 27. Global Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn
Figure 28. Global Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn
Figure 29. Global Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn
Figure 30. Global Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn
Figure 31. Global Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn
Figure 32. Global Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn
Figure 33. Global Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn
Figure 34. Global Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn
Figure 35. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn
Figure 36. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn
Figure 37. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn
Figure 38. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue
Figure 39. Contribution to Global 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 40. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn
Figure 41. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn
Figure 42. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn
Figure 43. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn
Figure 44. Global API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn
Figure 45. Global API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn
Figure 46. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn
Figure 47. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn
Figure 48. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue
Figure 49. Contribution to Global 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 50. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn
Figure 51. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn
Figure 52. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn
Figure 53. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn
Figure 54. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn
Figure 55. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn
Figure 56. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn
Figure 57. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn
Figure 58. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue
Figure 59. Contribution to Global 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 60. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn
Figure 61. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn
Figure 62. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn
Figure 63. Global Market Snapshot by Region
Figure 64. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2022-2032, % of Revenue
Figure 65. Contribution to Global 2023-2032 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 66. North American Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 67. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 68. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 69. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 70. Manufacturing Sites of APIs for U.S. Market by Country or Region,
Figure 71. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 72. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 73. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 74. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn
Figure 75. European Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 76. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 77. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 78. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn
Figure 79. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn
Figure 80. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn
Figure 81. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn
Figure 82. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn
Figure 83. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn
Figure 84. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn
Figure 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 86. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 87. Contribution to APAC 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 88. Active Pharmaceutical Ingredients (API) Market in China, 2022-2032, $ bn
Figure 89. Active Pharmaceutical Ingredients (API) Market in Japan, 2022-2032, $ bn
Figure 90. Active Pharmaceutical Ingredients (API) Market in India, 2022-2032, $ bn
Figure 91. Active Pharmaceutical Ingredients (API) Market in Australia, 2022-2032, $ bn
Figure 92. Active Pharmaceutical Ingredients (API) Market in South Korea, 2022-2032, $ bn
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2022-2032, $ bn
Figure 94. South America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 95. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 96. Contribution to South America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 97. Active Pharmaceutical Ingredients (API) Market in Argentina, 2022-2032, $ bn
Figure 98. Active Pharmaceutical Ingredients (API) Market in Brazil, 2022-2032, $ bn
Figure 99. Active Pharmaceutical Ingredients (API) Market in Chile, 2022-2032, $ bn
Figure 100. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2022-2032, $ bn
Figure 101. Active Pharmaceutical Ingredients (API) Market in MEA, 2022-2032, $ bn
Figure 102. Breakdown of MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 103. Contribution to MEA 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 104. Active Pharmaceutical Ingredients (API) Market in UAE, 2022-2032, $ bn
Figure 105. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2022-2032, $ bn
Figure 106. Active Pharmaceutical Ingredients (API) Market in South Africa, 2022-2032, $ bn
Figure 107. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 108. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022
Figure 109. AstraZeneca: Breakdown of Revenue by Region, 2022
Figure 110. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022
Figure 111. Boehringer Ingelheim: R&D Investement, 2019-2022
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Global Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2022, $ thousand
Figure 8. Leading Causes of Death in the World, 2000 and 2019, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Global Active Pharmaceutical Ingredients (API) Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Fiver Forces Analysis of Global Active Pharmaceutical Ingredients (API) Market
Figure 14. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Molecule, 2022-2032, % of Revenue
Figure 15. Global Addressable Market Cap in 2023-2032 by Molecule, Value ($ bn) and Share (%)
Figure 16. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Small Molecule APIs, 2022-2032, $ bn
Figure 17. Global Active Pharmaceutical Ingredients (API) Market by Molecule: Large Molecule APIs, 2022-2032, $ bn
Figure 18. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Synthesis, 2022-2032, % of Revenue
Figure 19. Contribution to Global 2023-2032 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 20. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Synthetic API, 2022-2032, $ bn
Figure 21. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Branded Synthetic API, 2022-2032, $ bn
Figure 22. Global Active Pharmaceutical Ingredients (API) Market by Synthetic API: Generic Synthetic API, 2022-2032, $ bn
Figure 23. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: Biotech API, 2022-2032, $ bn
Figure 24. Global Biotech API Market by Drug Type: Monoclonal Antibodies, 2022-2032, $ bn
Figure 25. Global Biotech API Market by Drug Type: Recombinant Proteins, 2022-2032, $ bn
Figure 26. Global Biotech API Market by Drug Type: Vaccines, 2022-2032, $ bn
Figure 27. Global Biotech API Market by Drug Type: Other Biotech APIs, 2022-2032, $ bn
Figure 28. Global Biotech API Market by Category: Innovative Biologic API, 2022-2032, $ bn
Figure 29. Global Biotech API Market by Category: Generic Biosimilar API, 2022-2032, $ bn
Figure 30. Global Biotech API Market by Expression Technology: Mammalian Expression, 2022-2032, $ bn
Figure 31. Global Biotech API Market by Expression Technology: Microbial Expression, 2022-2032, $ bn
Figure 32. Global Biotech API Market by Expression Technology: Yeast Expression, 2022-2032, $ bn
Figure 33. Global Biotech API Market by Expression Technology: Insect Expression, 2022-2032, $ bn
Figure 34. Global Biotech API Market by Expression Technology: Other Expression Technologies, 2022-2032, $ bn
Figure 35. Global Active Pharmaceutical Ingredients (API) Market by Synthesis: HPAPI, 2022-2032, $ bn
Figure 36. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Branded HPAPI, 2022-2032, $ bn
Figure 37. Global Active Pharmaceutical Ingredients (API) Market by HPAPI: Generic HPAPI, 2022-2032, $ bn
Figure 38. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2022-2032, % of Revenue
Figure 39. Contribution to Global 2023-2032 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 40. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Captive Manufacturing, 2022-2032, $ bn
Figure 41. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Branded Captive API, 2022-2032, $ bn
Figure 42. Global Active Pharmaceutical Ingredients (API) Market by Captive Manufacturing: Generic Captive API, 2022-2032, $ bn
Figure 43. Global Active Pharmaceutical Ingredients (API) Market by Manufacturing Process: Merchant Manufacturing, 2022-2032, $ bn
Figure 44. Global API Merchant Manufacturing Market by Drug Type: Branded Merchant API, 2022-2032, $ bn
Figure 45. Global API Merchant Manufacturing Market by Drug Type: Generic Merchant API, 2022-2032, $ bn
Figure 46. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Synthetic API, 2022-2032, $ bn
Figure 47. Global API Merchant Manufacturing Market by Drug Synthesis: Merchant Biotech API, 2022-2032, $ bn
Figure 48. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2022-2032, % of Revenue
Figure 49. Contribution to Global 2023-2032 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 50. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Infectious Diseases, 2022-2032, $ bn
Figure 51. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Oncology, 2022-2032, $ bn
Figure 52. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Ophthalmology, 2022-2032, $ bn
Figure 53. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Cardiovascular Disorders, 2022-2032, $ bn
Figure 54. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Central Nervous System, 2022-2032, $ bn
Figure 55. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Pulmonary Disorders, 2022-2032, $ bn
Figure 56. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Orthopedics, 2022-2032, $ bn
Figure 57. Global Active Pharmaceutical Ingredients (API) Market by Therapeutic Application: Other Applications, 2022-2032, $ bn
Figure 58. Breakdown of Global Active Pharmaceutical Ingredients (API) Market by Drug Type, 2022-2032, % of Revenue
Figure 59. Contribution to Global 2023-2032 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 60. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Branded Prescription Drugs, 2022-2032, $ bn
Figure 61. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: Generic Prescription Drugs, 2022-2032, $ bn
Figure 62. Global Active Pharmaceutical Ingredients (API) Market by Drug Type: OTC Drugs, 2022-2032, $ bn
Figure 63. Global Market Snapshot by Region
Figure 64. Geographic Spread of Worldwide Active Pharmaceutical Ingredients (API) Market, 2022-2032, % of Revenue
Figure 65. Contribution to Global 2023-2032 Cumulative Revenue by Region, Value ($ bn) and Share (%)
Figure 66. North American Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 67. Breakdown of North America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 68. Contribution to North America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 69. U.S. Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 70. Manufacturing Sites of APIs for U.S. Market by Country or Region,
Figure 71. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 72. Number and Percentage of API Facilities for the 370 U.S. Marketed Drugs on the 2019 WHO Essential Medicines List
Figure 73. Canada Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 74. Active Pharmaceutical Ingredients (API) Market in Mexico, 2022-2032, $ bn
Figure 75. European Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 76. Breakdown of European Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 77. Contribution to Europe 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 78. Active Pharmaceutical Ingredients (API) Market in UK, 2022-2032, $ bn
Figure 79. Active Pharmaceutical Ingredients (API) Market in France, 2022-2032, $ bn
Figure 80. Active Pharmaceutical Ingredients (API) Market in Germany, 2022-2032, $ bn
Figure 81. Active Pharmaceutical Ingredients (API) Market in Spain, 2022-2032, $ bn
Figure 82. Active Pharmaceutical Ingredients (API) Market in Italy, 2022-2032, $ bn
Figure 83. Active Pharmaceutical Ingredients (API) Market in Russia, 2022-2032, $ bn
Figure 84. Active Pharmaceutical Ingredients (API) Market in Rest of Europe, 2022-2032, $ bn
Figure 85. Asia-Pacific Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 86. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 87. Contribution to APAC 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 88. Active Pharmaceutical Ingredients (API) Market in China, 2022-2032, $ bn
Figure 89. Active Pharmaceutical Ingredients (API) Market in Japan, 2022-2032, $ bn
Figure 90. Active Pharmaceutical Ingredients (API) Market in India, 2022-2032, $ bn
Figure 91. Active Pharmaceutical Ingredients (API) Market in Australia, 2022-2032, $ bn
Figure 92. Active Pharmaceutical Ingredients (API) Market in South Korea, 2022-2032, $ bn
Figure 93. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2022-2032, $ bn
Figure 94. South America Active Pharmaceutical Ingredients (API) Market, 2022-2032, $ bn
Figure 95. Breakdown of South America Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 96. Contribution to South America 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 97. Active Pharmaceutical Ingredients (API) Market in Argentina, 2022-2032, $ bn
Figure 98. Active Pharmaceutical Ingredients (API) Market in Brazil, 2022-2032, $ bn
Figure 99. Active Pharmaceutical Ingredients (API) Market in Chile, 2022-2032, $ bn
Figure 100. Active Pharmaceutical Ingredients (API) Market in Rest of South America, 2022-2032, $ bn
Figure 101. Active Pharmaceutical Ingredients (API) Market in MEA, 2022-2032, $ bn
Figure 102. Breakdown of MEA Active Pharmaceutical Ingredients (API) Market by Country, 2022 and 2032, % of Revenue
Figure 103. Contribution to MEA 2023-2032 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 104. Active Pharmaceutical Ingredients (API) Market in UAE, 2022-2032, $ bn
Figure 105. Active Pharmaceutical Ingredients (API) Market in Saudi Arabia, 2022-2032, $ bn
Figure 106. Active Pharmaceutical Ingredients (API) Market in South Africa, 2022-2032, $ bn
Figure 107. Growth Stage of Global Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 108. AstraZeneca: Breakdown of Revenue by Therapy Area, 2022
Figure 109. AstraZeneca: Breakdown of Revenue by Region, 2022
Figure 110. Boehringer Ingelheim: Revenue by Business Segment, 2019-2022
Figure 111. Boehringer Ingelheim: R&D Investement, 2019-2022
